Prominent CIO sees health IT as a force for stability, innovation

Cara Livernois | | Health Exec | Precision Medicine

Rick Hopfer, CIO at Molina Healthcare, has implemented a three-year plan to help the company in “stabilizing, optimizing, and innovating business operations." In an interview with Forbes, Hopfer explains future plans and just how he predicts health IT will affect the whole of healthcare.

"I would not say that we are an aggressive adopter of technology, but we are on the forefront of where we need to be as a company," Hopfer said in the interview. "We are looking at those companies that are disrupting industries, like an Uber might, and in healthcare there may be some companies coming up that we may want to keep an eye on."

Read the full story below:

IT Innovation At One Of The Fastest Growing Healthcare Companies In The World

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Cardiovascular Business
Cardiology groups cheer new bill that would improve access to Medicare claims data

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup